Figures & data
Figure 1 Schematic of the preparation process of Mt-BH-LPs.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.
![Figure 1 Schematic of the preparation process of Mt-BH-LPs.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.](/cms/asset/02c933ce-05ba-4a6d-8070-bde8390f363a/dijn_a_12193470_f0001_c.jpg)
Figure 2 Schematic diagram of the in vitro tear-turnover apparatus.
Notes: The model incorporated an insert containing cultured corneal tissue as a turnover chamber; the external basal side of the insert was sealed to avoid a downward diffusion of material. The system was temperature-controlled at human tear-film temperature (34°C). Constant in- and outflow of simulated tears in the chamber were controlled by peristaltic pumps.
Abbreviations: STF, simulated tear fluid; iHCEC, immortalized human corneal epithelial cell.
![Figure 2 Schematic diagram of the in vitro tear-turnover apparatus.Notes: The model incorporated an insert containing cultured corneal tissue as a turnover chamber; the external basal side of the insert was sealed to avoid a downward diffusion of material. The system was temperature-controlled at human tear-film temperature (34°C). Constant in- and outflow of simulated tears in the chamber were controlled by peristaltic pumps.Abbreviations: STF, simulated tear fluid; iHCEC, immortalized human corneal epithelial cell.](/cms/asset/4c4ee95c-d58d-4f3d-a939-91771482e1c6/dijn_a_12193470_f0002_c.jpg)
Figure 3 Time to dialysis equilibrium of Mt-BH-LPs
Abbreviation: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.
![Figure 3 Time to dialysis equilibrium of Mt-BH-LPsAbbreviation: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.](/cms/asset/9874acd6-f956-4798-bc37-04e28d4d0d69/dijn_a_12193470_f0003_b.jpg)
Figure 4 Particle-size distribution of (A) BH-LPs and (B) Mt-BH-LPs.
Note: The red line indicates cumulative distribution. The black line inidates the percentage of the particle size. f, differential intensity.
Abbreviation: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.
![Figure 4 Particle-size distribution of (A) BH-LPs and (B) Mt-BH-LPs.Note: The red line indicates cumulative distribution. The black line inidates the percentage of the particle size. f, differential intensity.Abbreviation: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.](/cms/asset/62303ec3-aaa5-490f-af62-d6c3562d9697/dijn_a_12193470_f0004_c.jpg)
Figure 5 TEM images of (A, B) BH-LPs and (C, D) Mt-BH-LPs.
Note: (B and D) show magnification of red squares in (A and C), respectively.
Abbreviations: TEM, transmission electron microscopy; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.
![Figure 5 TEM images of (A, B) BH-LPs and (C, D) Mt-BH-LPs.Note: (B and D) show magnification of red squares in (A and C), respectively.Abbreviations: TEM, transmission electron microscopy; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes.](/cms/asset/34f00058-568b-4cd5-b982-278ed2986611/dijn_a_12193470_f0005_c.jpg)
Figure 6 (A) XRD patterns of BH, acid-Mt, Mt-BH, acid-Mt + BH BH-LPs, and Mt-BH-LPs; (B) enlarged XRD patterns of acid-Mt and Mt-BH.
Abbreviations: XRD, X-ray diffraction; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.
![Figure 6 (A) XRD patterns of BH, acid-Mt, Mt-BH, acid-Mt + BH BH-LPs, and Mt-BH-LPs; (B) enlarged XRD patterns of acid-Mt and Mt-BH.Abbreviations: XRD, X-ray diffraction; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.](/cms/asset/ac990419-09d3-4ebe-afd1-fd0dba75d884/dijn_a_12193470_f0006_c.jpg)
Figure 7 (A) TGA and (B) DSC pattern of BH, acid-Mt, Mt-BH, BH-LPs, and Mt-BH-LPs.
Abbreviations: TGA, thermogravimetric analysis; DSC, differential scanning calorimetry; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.
![Figure 7 (A) TGA and (B) DSC pattern of BH, acid-Mt, Mt-BH, BH-LPs, and Mt-BH-LPs.Abbreviations: TGA, thermogravimetric analysis; DSC, differential scanning calorimetry; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.](/cms/asset/73ebcf3a-0ca5-4f7a-9314-e6459c395ac8/dijn_a_12193470_f0007_c.jpg)
Figure 8 FTIR spectra of acid-Mt, BH, Mt-BH, and Mt-BH-LPs.
Abbreviations: FTIR, Fourier-transform infrared; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.
![Figure 8 FTIR spectra of acid-Mt, BH, Mt-BH, and Mt-BH-LPs.Abbreviations: FTIR, Fourier-transform infrared; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; Mt, montmorillonite.](/cms/asset/82ecaeb8-616d-4996-8581-1095ccadbe2b/dijn_a_12193470_f0008_c.jpg)
Figure 9 In vitro release curves of BH solution, BH-LPs, and Mt-BH-LPs.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 9 In vitro release curves of BH solution, BH-LPs, and Mt-BH-LPs.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/58e41630-7046-43da-87bc-585d1988396c/dijn_a_12193470_f0009_c.jpg)
Figure 10 Cell viability of (A) Betoptic, (B) BH solution, (C) blank LPs, and (D) Mt-BH-LPs at different exposure times and amounts.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 10 Cell viability of (A) Betoptic, (B) BH solution, (C) blank LPs, and (D) Mt-BH-LPs at different exposure times and amounts.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/b0e5b437-d682-4236-b59e-0b79fcd0c183/dijn_a_12193470_f0010_c.jpg)
Figure 11 Viability of iHCECs with differing amounts of Betoptic, BH solution, blank LPs, and Mt-BH-LPs exposure for 2 hours.
Abbreviations: iHCECs, immortalized human corneal epithelial cells; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 11 Viability of iHCECs with differing amounts of Betoptic, BH solution, blank LPs, and Mt-BH-LPs exposure for 2 hours.Abbreviations: iHCECs, immortalized human corneal epithelial cells; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/4db937ce-00b4-49af-9534-65bed0a1f2a9/dijn_a_12193470_f0011_c.jpg)
Table 1 Draize test scores
Figure 12 Cornea histopathology by microscopy.
Notes: (A) Normal cornea, (B) treated with saline, (C) treated with Betoptic, (D) treated with BH solution, and (E) treated with Mt-BH-LPs.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 12 Cornea histopathology by microscopy.Notes: (A) Normal cornea, (B) treated with saline, (C) treated with Betoptic, (D) treated with BH solution, and (E) treated with Mt-BH-LPs.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/8d648ded-1a5e-412f-97a1-abfda8228a11/dijn_a_12193470_f0012_c.jpg)
Figure 13 Conjunctival histopathology by microscopy.
Notes: (A) Normal cornea, (B) treated with saline, (C) treated with Betoptic, (D) treated with BH solution, and (E) treated with Mt-BH-LPs.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 13 Conjunctival histopathology by microscopy.Notes: (A) Normal cornea, (B) treated with saline, (C) treated with Betoptic, (D) treated with BH solution, and (E) treated with Mt-BH-LPs.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/c756e4e4-0706-4cdd-bd1b-40329673cb2b/dijn_a_12193470_f0013_c.jpg)
Figure 14 (A) Hemorrhage situation and (B) trypan blue absorption of CAM.
Abbreviations: NS, normal saline; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; CAM, chorioallantoic membrane.
![Figure 14 (A) Hemorrhage situation and (B) trypan blue absorption of CAM.Abbreviations: NS, normal saline; Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride; CAM, chorioallantoic membrane.](/cms/asset/a715a3d3-2f17-4d7a-a995-d1a132f07c66/dijn_a_12193470_f0014_c.jpg)
Figure 15 Frozen section of stratified immortalized human cornea epithelial cells.
Note: Fluorescence microscope image (magnification 400×).
![Figure 15 Frozen section of stratified immortalized human cornea epithelial cells.Note: Fluorescence microscope image (magnification 400×).](/cms/asset/d4a21d80-3dcc-4db5-90f7-4dfd74166b03/dijn_a_12193470_f0015_c.jpg)
Figure 16 Concentration–time curve in the cornea/tear-film compartment after topical application of BH solution and Mt-BH-LPs.
Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.
![Figure 16 Concentration–time curve in the cornea/tear-film compartment after topical application of BH solution and Mt-BH-LPs.Abbreviations: Mt-BH-LPs, montmorillonite–betaxolol hydrochloride liposomes; BH, betaxolol hydrochloride.](/cms/asset/72b53aef-8bdf-480f-bbd2-70aa27653e6d/dijn_a_12193470_f0016_c.jpg)
Table 2 Pharmacokinetics parameters of BH in tears after topical administration in rabbits